Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aytu Biopharma (AYTU) Return on Capital Employed: 2011-2025

Historic Return on Capital Employed for Aytu Biopharma (AYTU) over the last 15 years, with Jun 2025 value amounting to 0.13%.

  • Aytu Biopharma's Return on Capital Employed fell 10.00% to 0.14% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.14%, marking a year-over-year decrease of 10.00%. This contributed to the annual value of 0.13% for FY2025, which is 10.00% down from last year.
  • Aytu Biopharma's Return on Capital Employed amounted to 0.13% in FY2025, which was down 302.37% from 0.03% recorded in FY2024.
  • Aytu Biopharma's 5-year Return on Capital Employed high stood at 0.03% for FY2024, and its period low was 0.80% during FY2022.
  • For the 3-year period, Aytu Biopharma's Return on Capital Employed averaged around 0.14%, with its median value being 0.13% (2025).
  • In the last 5 years, Aytu Biopharma's Return on Capital Employed decreased by 26bps in 2021 and then soared by 55bps in 2023.
  • Over the past 5 years, Aytu Biopharma's Return on Capital Employed (MRY) stood at 0.59% in 2021, then tumbled by 36bps to 0.80% in 2022, then surged by 69bps to 0.25% in 2023, then skyrocketed by 87bps to 0.03% in 2024, then plummeted by 302bps to 0.13% in 2025.
  • Its Return on Capital Employed was 0.13% in FY2025, compared to 0.03% in FY2024 and 0.25% in FY2023.